News & Perspective

(CIDRAP News) – A five-country study from Europe indicates that the use of adjuvanted vaccines against the pandemic H1N1 influenza virus probably did not increase the risk of Guillain-Barre syndrome (GBS), but the investigators could not firmly rule out a slightly greater chance of suffering the paralytic condition.

(CIDRAP News) – In the largest study of its kind so far to assess how well 2009 H1N1 vaccines performed in the pandemic setting, new findings from seven European countries showed they provided good protection, a result that mirrors early clinical studies.

(CIDRAP News) – A thorough surveillance study from France reinforces findings from other countries about obesity and delayed antiviral treatment as risk factors for severe 2009 H1N1 influenza, while indicating that the pandemic put a greater burden on intensive care units (ICUs) than seasonal flu typically does.